Gen-Probe, Inc. (NASDAQ:GPRO)
The Company is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid probe-based products used for the clinical diagnosis of human diseases and for screening donated human blood.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
RutledgeAvenue
(44.09)
Submitted: 1/6/2011 11:21:27 AM :
Start Price:
$46.71
GPRO Score:
+32.42
0% D/E and positive EPS trend in a critical service oriented market. Great opportunity.
Recs
kevinottofro
(97.89)
Submitted: 11/7/2009 8:43:54 AM :
Start Price:
$41.39
GPRO Score:
+73.79
low relative PE, good star & 2010 earnings. Bottom fishing week of 10/26.
Recs
hardrockfool
(< 20)
Submitted: 11/2/2009 3:09:32 PM :
Start Price:
$40.95
GPRO Score:
+71.27
Their H1N1 flu test was just emergency approved by the FDA.
Recs
visibleinvesting
(73.89)
Submitted: 8/10/2009 12:53:23 AM :
Start Price:
$37.84
GPRO Score:
+82.81
GPRO's patented testing will save government, insurance companies, individuals money. These products and services are going at the heart of the health care system. this company is selling for 50 cents on the dollar because of some short term, non repeatable problems. It's not often you can invest in a company with the economics and social impact of GPRO at such a low valuation.
Recs
Recs
BigSteve590
(51.38)
Submitted: 3/27/2008 9:02:17 AM :
Start Price:
$48.31
GPRO Score:
+65.98
Gen-Probe is a leader in molecular diagnostics. It has tests for HIV and Hepatitis B and C, and is developing a more-reliable prostate cancer screening test.
Recs
doggetla
(66.46)
Submitted: 3/24/2008 6:49:27 PM :
Start Price:
$49.00
GPRO Score:
+64.11
just "discovered" this stock, healthcare is the sector to be in during a recession.
Recs
troyton
(< 20)
Submitted: 3/24/2008 5:11:18 PM :
Start Price:
$49.00
GPRO Score:
+64.11
GPRO's market is back.
Recs
jfielhauer
(< 20)
Submitted: 1/7/2008 11:32:53 AM :
Start Price:
$62.13
GPRO Score:
+33.44
Nucleic acid amplification testing (which is the same thing as PCR)is a cheap and reliable technology that can be used for the detection of any viral or bacterial infection. For the detection of pathogens this is the best method.
Recs
ZoomAddict111
(< 20)
Submitted: 12/1/2007 8:28:16 AM :
Start Price:
$67.11
GPRO Score:
+27.59
Great products and diagnostics is a great sector. Their prostate test is actually accurate (beats the pants off the standard PSA test that is only about 25% accurate).
Recs
tharlow
(31.04)
Submitted: 11/29/2007 6:36:13 AM :
Start Price:
$66.72
GPRO Score:
+27.29
Should be $100 by Christmas.
Recs
longshort87
(86.16)
Submitted: 11/13/2007 5:48:39 PM :
Start Price:
$64.00
GPRO Score:
+34.11
Impressive portfolio of intellectual property related to nucleic acid testing and a solid operating record of transferring that IP into commercially successful products with recurring revenue streams. Rich pipeline of future products, $6/share of cash, zero debt, mid-high teens organic revenue growth. Also potentially an attractive takeover target for a larger diagnostics firm (Roche? Abbott?)
Recs
Lauder
(< 20)
Submitted: 7/24/2007 12:45:12 PM :
Start Price:
$60.77
GPRO Score:
+42.89
Medical play with a long-term view
Recs
pSH51
(< 20)
Submitted: 7/13/2007 9:55:27 AM :
Start Price:
$60.67
GPRO Score:
+43.87
WHO DOESNT LIKE MEDICINE
Recs
Recs
pinorload
(84.81)
Submitted: 3/23/2007 3:18:10 AM :
Start Price:
$47.00
GPRO Score:
+75.27
Biological testing doesn't get interrupted by bad economies, especially when a company has elite technology.
Recs
lloydparker
(< 20)
Submitted: 3/11/2007 1:53:46 PM :
Start Price:
$48.41
GPRO Score:
+67.86
GPRO is ready to market a rapid test for the West Nile Virus to test sites through Chiron. This is a huge step forward for a company with a large portfolio of bloodwork analysis tools already out there.
Recs
Eagle715
(< 20)
Submitted: 11/29/2006 5:53:48 PM :
Start Price:
$48.97
GPRO Score:
+65.94
Their products will be used increasingly by more medical facilities.
Recs
TheEndz
(96.80)
Submitted: 10/4/2006 9:38:03 PM :
Start Price:
$46.76
GPRO Score:
+69.69
A biotech that has great things going in the future, and all the large drug companies are watching. Could be bought out some day, but don't wait for that Buy now....
Recs
twinthai
(< 20)
Submitted: 8/26/2006 8:43:28 AM :
Start Price:
$48.09
GPRO Score:
+60.22
GPRO manufacturers and markets NAT-based (nucleir acid testing) products used in clinical iagonoses of infectious diseases such as HIV and hepatitis C--growing 15% per year; plus blood screening--80% of US market; and industrial testing. 25% growth in annual rev's over past 3 years; it continues to expand its exiting product line and nowdistribution as well through Chiron (now part of Novartis). No debt! Not widely followed. Entered into collaboration with Millipore to develop NAT assays for ptoential drug candidates, which will aid drug companies expedite screening process. Partnership with GE to develop technologies to detect bacteria in food and water--3 billion USD market.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 20